Chromovitrevictomy for ERM and macular hole
Conditions
Interventions
Sponsors
Kyusyu University Hospital, Ohshima Hospital of Ophthalmology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients required for vitrectomy in one or both eyes Primary diseases for vitrectomy are macular hole, epiretinal macular membrane, macular hole retinal detachment cased by high myopia , proliferativevitreoretinopathy, preproliferative diabetic retinopathy, diabetic macular edema, macular edema cased by occlusion of retinal vein, and stainig and peeling of internal limiting membrane in vitrectomy are necessary. 2) Age : >=20 years old at the time of obtaining informed consent 3) Male or female passed 2 years after menopause 4) Patients comply with the schedule instructed by PI or SI 5) Patients take part in this trial based on their own free will and give informed consent in written form.
Exclusion criteria
Exclusion criteria: 1) Vitrectomized eye. 2) Has serious of digestive, circulatory, kidney, liver, or blood/coagulation complications 3) Had present and past uveitis or glaucoma 4) Has a history of drug hypersensitivity reactions for Triamcinolone acetonide, mydriatic, antibacterial eyedrops or local anesthetic. 5) Has a history of drug or alcohol abuse 6) Had taken this clinical trial 7) Will take part in in another clinical trial or clinical research during this clinical trial 8) Is deemed unsuitable for this trial by PI or SI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma concentrations of BBG after chromovitrectomy | — |
Secondary
| Measure | Time frame |
|---|---|
| Vitreous concentrations of BBG after chromovitrectomy | — |
Countries
Japan
Contacts
Public ContactMakiko Uchiyama
Kyusyu University Hospital Center for Clinical and Translational Research
Outcome results
None listed